In the BioHarmony Drug Report Database
Mefloquine
Lariam, Mefloquine (mefloquine) is a small molecule pharmaceutical. Mefloquine was first approved as Lariam on 1989-05-02. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target adenosine receptor A1, adenosine receptor A2a, and purine nucleoside phosphorylase.
Trade Name
|
Lariam, Mefloquine |
|---|---|
Common Name
|
mefloquine |
ChEMBL ID
|
CHEMBL416956 |
Indication
|
falciparum malaria, malaria, vivax malaria |
Drug Class
|
Image (chem structure or protein)